Wuxi High-Mountain Successfully Concludes Participation at CPHI China 2025

Wuxi High-Mountain Technology has successfully concluded its participation at CPHI China 2025, held from June 24 to 26 at the Shanghai New International Expo Centre. Over the course of three days, the company welcomed a steady flow of visitors to Booth E11A25, generating strong interest in its core offerings and establishing valuable new connections.

At this year’s exhibition, Wuxi High-Mountain showcased its key product lines, including Pharmaceutical Intermediates and Chemical Additives, which received highly positive feedback from domestic and international clients. Visitors expressed particular interest in the company’s high-purity, GMP-compliant intermediates, custom synthesis capabilities, and end-to-end service solutions for pharmaceutical and fine chemical applications.

Throughout the event, our team engaged in a wide range of technical discussions, business negotiations, and potential partnership conversations. Many guests requested on-site consultations, product samples, and follow-up meetings for further collaboration.

The exhibition also provided an excellent opportunity to reconnect with long-standing partners and explore future strategies for growth in the global pharmaceutical supply chain.

We sincerely thank all our visitors, partners, and colleagues for their time, trust, and support during CPHI China 2025. The strong interest and positive feedback we received reaffirm our mission to provide reliable, innovative, and high-quality chemical solutions to clients worldwide.

For follow-up inquiries or cooperation discussions:
Email: harold@high-mountain.cn
Phone: +86 133 8222 3993
Website: www.high-mountain.cn